Tiziana Life Sciences Announces Death of Director
13 janv. 2022 07h00 HE
|
Tiziana Life Sciences Ltd.
NEW YORK, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences (Nasdaq: TLSA) (“Tiziana”), a biotechnology company enabling breakthrough immunotherapies via novel routes of drug delivery, today...
Tiziana Enrolls Second Patient in Ongoing Intranasal Foralumab Evaluation for Secondary Progressive Multiple Sclerosis
10 janv. 2022 07h00 HE
|
Tiziana Life Sciences Ltd.
- Clinical data from the first patient, after completing 3 out of 6 months, suggest that the treatment was well tolerated with a favorable clinical response - FDA allows for continued enrollment...
Tiziana Life Sciences to Participate in 2022 Biotech Showcase Virtual Investor Conference
06 janv. 2022 16h15 HE
|
Tiziana Life Sciences Plc
NEW YORK, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences (Nasdaq: TLSA) (“Tiziana”), a biotechnology company enabling breakthrough immunotherapies via novel routes of drug delivery, today...
Share Capital Consolidation and Commencement of trading in the New Tiziana Shares on NASDAQ
21 oct. 2021 02h00 HE
|
Tiziana Life Sciences Plc
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU WHICH IS PART OF DOMESTIC UK LAW PURSUANT TO THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS...
Tiziana Life Sciences - Scheme Effective Date
20 oct. 2021 09h40 HE
|
Tiziana Life Sciences Plc
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU WHICH IS PART OF DOMESTIC UK LAW PURSUANT TO THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS...
Tiziana Life Sciences plc: PDMR Dealing
20 oct. 2021 02h00 HE
|
Tiziana Life Sciences Plc
LONDON and NEW YORK, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (Nasdaq: TLSA / LSE: TILS) ("Tiziana" or the "Company"), a biotechnology company focused on innovative therapeutics...
Tiziana Life Sciences plc: Court Sanctions the Scheme of Arrangement and approves Reduction of Capital
19 oct. 2021 09h26 HE
|
Tiziana Life Sciences Plc
LONDON and NEW YORK, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (Nasdaq: TLSA / LSE: TILS) ("Old Tiziana") a biotechnology company focused on innovative therapeutics for oncology,...
Tiziana Life Sciences plc: PDMR Dealing
28 sept. 2021 04h19 HE
|
Tiziana Life Sciences Plc
LONDON and NEW YORK, Sept. 28, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (Nasdaq: TLSA / LSE: TILS) ("Tiziana" or the "Company"), a biotechnology company focused on innovative therapeutics...
Tiziana Life Sciences Plc - Results of Court Meeting and General Meeting
27 sept. 2021 12h39 HE
|
Tiziana Life Sciences Plc
LONDON, Sept. 27, 2021 (GLOBE NEWSWIRE) -- On 20 August 2021, Tiziana Life Sciences Plc (“Old Tiziana”) announced that it has formally commenced its strategic plan to change its corporate structure...
Tiziana Life Sciences plc - Interim Results for the Six Months Ended 30 June 2021
24 sept. 2021 12h51 HE
|
Tiziana Life Sciences Plc
LONDON, Sept. 24, 2021 (GLOBE NEWSWIRE) -- London, 24 September 2021 – Tiziana Life Sciences plc (“Tiziana”, LSE: TILS, NASDAQ: TLSA), a biotechnology company a biotechnology company focused on...